引用本文
  •    [点击复制]
  •    [点击复制]
PDF HTML全文阅读
本文已被:浏览 32次   下载 1 本文二维码信息
码上扫一扫!
宣白承气汤干预缺氧诱导因子-1α炎症相关途径减轻大鼠肺缺血再灌注损伤的机制
韩文恒,王顺华,曲鹏飞,刘麒,王红
天津中医药大学第二附属医院普通外科天津 300250;天津中医药大学研究生院天津 301617
摘要:
目的:探讨宣白承气汤干预缺氧诱导因子-1α(HIF-1α)炎症相关途径减轻大鼠肺缺血再灌注损伤(LIRI)的机制。方法:选取40只健康雄性SD大鼠,随机分为假手术组、LIRI组、宣肺组及宣白承气汤组,每组10只。通过测定肺组织湿干重比(W/D)评估其水肿程度;利用肺标本HE染色进行病理学观察,并行损伤程度评分;利用蛋白质印迹(Western blot)法检测肺组织HIF-1α蛋白表达,酶联免疫吸附实验(ELISA)法检测血清肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)含量。结果:与假手术组比较,LIRI组、宣肺组及宣白承气汤组的W/D比值均有升高,差异具有统计学意义(P <0.05);而与LIRI组比较,宣肺组及宣白承气汤组的W/D下降,其中宣白承气汤组更低,差异具有统计学意义(P <0.05);HE染色镜下观察,LIRI组、宣肺组及宣白承气汤组肺组织均出现不同程度损伤,而与LIRI组比较,宣肺组及宣白承气汤组肺损伤评分有所降低,且宣白承气汤组肺损伤改善情况更显著,差异具有统计学意义(P <0.05);与假手术组比较,LIRI组、宣肺组及宣白承气汤组的HIF-1α、TNF-α及IL-1β的含量均有升高,宣肺组及宣白承气汤组的上述指标含量均低于LIRI组,且宣白承气汤组的指标降低更显著,差异具有统计学意义(P <0.05)。结论:宣白承气汤可能通过调节HIF-1α的蛋白表达抑制炎性因子水平,从而缓解大鼠肺缺血再灌注造成的损伤。
关键词:  宣白承气汤  肺缺血再灌注损伤  缺氧诱导因子-1α  炎症
DOI:10.3969/j.issn.1007-6948.2026.04.019
投稿时间:2025-12-20
基金项目:天津市教委科研计划项目(2019KJ050)
Mechanism of Xuanbai Chengqi decoction intervention on HIF-1α and inflammation related pathways to alleviate lung ischemia-reperfusion injury in rats
HAN Wen-heng,WANG Shun-hua,QU Peng-fei
Abstract:
Objective To investigate the effects of Xuanbai Chengqi decoction on lung ischemia-reperfusion injury in rats and analyze the mechanism of HIF-1α and inflammatory pathway in this process. Methods Forty healthy male SD rats were randomly divided into sham operation group (Sham), lung ischemia-reperfusion injury group (LIRI), Xuanfei group, and Xuanbai Chengqi decoction group. The degree of edema was assessed by measuring the wet-to-dry weight (W/D)ratio of lung tissue; pathological observations were conducted using HE staining of lung specimens, and the degree of injury was scored; meanwhile, protein expression of HIF-1α in lung tissue was measured by Western blot, and the levels of serum TNF-α and IL-1β were detected by ELISA. Results Compared to the Sham group, the W/D ratio increased in the LIRI group, Xuanfei group, and Xuanbai Chengqi decoction group. However, compared to the LIRI group, the Xuanfei group and Xuanbai Chengqi decoction group showed decreased performance in W/D ratio, with the Xuanbai Chengqi decoction group exhibiting lower data, and the differences were statistically significant (P <0.05). Under HE staining microscopy, varying degrees of damage were observed in the lung tissues of the LIRI group, Xuanfei group, and Xuanbai Chengqi decoction group. Compared to the LIRI group, the lung injury scores in the Xuanfei group and Xuanbai Chengqi decoction group decreased, with the Xuanbai Chengqi decoction group showing more significant improvement in lung injury, and the differences were statistically significant (P <0.05). The levels of HIF-1α, TNF-α, and IL-1β increased in the LIRI group, Xuanfei group, and Xuanbai Chengqi decoction group. However, compared to the LIRI group, the levels in the Xuanfei group and Xuanbai Chengqi decoction group decreased, with the Xuanbai Chengqi decoction group showing more significant reductions, and the differences were statistically significant (P <0.05). Conclusion Xuanbai Chengqi decoction may alleviate lung ischemia-reperfusion injury in rats by regulating the protein expression of HIF-1α and inhibiting inflammatory factor levels.
Key words:  Xuanbai Chengqi decoction  lung ischemia-reperfusion injury  HIF-1α  inflammation

用微信扫一扫

用微信扫一扫